Advertisement

Topics

FDA clears BioStable's HAART 200 aortic annuloplasty device

06:39 EDT 16 Aug 2017 | SmartBrief

The FDA gave BioStable Science & Engineering clearance to market its HAART 200 aortic annuloplasty device, which is indicated -More

Original Article: FDA clears BioStable's HAART 200 aortic annuloplasty device

NEXT ARTICLE

More From BioPortfolio on "FDA clears BioStable's HAART 200 aortic annuloplasty device"

Advertisement
Quick Search
Advertisement
Advertisement